Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Elife. 2017 Sep 1;6:e23708. doi: 10.7554/eLife.23708.
The molecular force of blood-stage infection (FOB) is a quantitative surrogate metric for malaria transmission at population level and for exposure at individual level. Relationships between FOB, parasite prevalence and clinical incidence were assessed in a treatment-to-reinfection cohort, where () hypnozoites were eliminated in half the children by primaquine (PQ). Discounting relapses, children acquired equal numbers of new () and blood-stage infections/year (FOB = 0-18, FOB = 0-23) resulting in comparable spatial and temporal patterns in incidence and prevalence of infections. Including relapses, FOB increased >3 fold (relative to PQ-treated children) showing greater heterogeneity at individual (FOB = 0-36) and village levels. and FOB were strongly associated with clinical episode risk. Yearly clinical incidence rate (IR = 0.28) was higher than for (IR = 0.12) despite lower FOB. These relationships between FOB, clinical incidence and parasite prevalence reveal a comparable decline in and transmission that is normally hidden by the high burden of relapses.
ClinicalTrials.gov NCT02143934.
血液阶段感染的分子力(FOB)是衡量人群疟疾传播水平和个体暴露水平的定量替代指标。在一个治疗-再感染队列中评估了 FOB、寄生虫流行率和临床发病率之间的关系,其中一半儿童通过伯氨喹(PQ)消除了休眠疟原虫。不计复发,儿童每年获得相同数量的新 ()和 血液阶段感染/年(FOB = 0-18,FOB = 0-23),导致感染的发病率和流行率具有相似的空间和时间模式。包括复发在内,FOB 增加了 >3 倍(与 PQ 治疗的儿童相比),显示出个体(FOB = 0-36)和村庄水平的更大异质性。 和 FOB 与临床发作风险密切相关。每年的 临床发病率(IR = 0.28)高于 (IR = 0.12),尽管 FOB 较低。FOB、临床发病率和寄生虫流行率之间的这些关系揭示了 和 的传播呈可比下降趋势,而复发的高负担通常掩盖了这种下降趋势。
ClinicalTrials.gov NCT02143934。